Balasa Dinverno & Foltz Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSJH
Guggenheim BulletShares 2017 High Yield Corporate Bond ETF
BSJH
|
+$31.1M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$3.14M |
| 3 |
SWI
SOLARWINDS INC COM STK (DE)
SWI
|
+$2.6M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.21M |
| 5 |
BSJG
Guggenheim BulletShares 2016 High Yield Corporate Bond ETF
BSJG
|
+$2.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSJE
GUGGENGEIM BULLETSHARES 2014 HIGH YIELD CORPORATE BOND ETF
BSJE
|
+$30.6M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$255K |
| 3 |
EOG Resources
EOG
|
+$217K |
| 4 |
iShares MSCI EAFE Growth ETF
EFG
|
+$172K |
| 5 |
Equity Residential
EQR
|
+$149K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Consumer Discretionary | 2.39% |
| 3 | Healthcare | 1.39% |
| 4 | Financials | 1.35% |
| 5 | Communication Services | 1.01% |
Similar funds
Balasa Dinverno & Foltz's Q2 2014 Portfolio in Review
As of Q2 2014, Balasa Dinverno & Foltz held 179 positions worth $872M, up 6.5% from $818M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Balasa Dinverno & Foltz's Q2 2014 filing shows 17 new, 86 increased, 58 reduced and 1 closed positions. Its largest new stake was Guggenheim BulletShares 2017 High Yield Corporate Bond ETF: 1,130,252 shares worth $25.9M. The largest sale was GUGGENGEIM BULLETSHARES 2014 HIGH YIELD CORPORATE BOND ETF, an estimated $30.6M.
By sector, the portfolio is most concentrated in Technology at 3% of assets, up from 2.9% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Balasa Dinverno & Foltz's largest Q2 2014 buy was Guggenheim BulletShares 2017 High Yield Corporate Bond ETF: 1,130,252 shares worth $25.9M.
- Balasa Dinverno & Foltz added most to iShares Russell 1000 Growth ETF in Q2 2014, an estimated $3.14M increase.
- Balasa Dinverno & Foltz's biggest Q2 2014 reduction was GUGGENGEIM BULLETSHARES 2014 HIGH YIELD CORPORATE BOND ETF, cutting an estimated $30.6M.
- Balasa Dinverno & Foltz fully exited Mead Johnson Nutrition Company in Q2 2014, selling an estimated $255K.
- Balasa Dinverno & Foltz's ten largest holdings make up 86% of its $872M portfolio in Q2 2014.
- Balasa Dinverno & Foltz opened 17 new positions and closed 1 in Q2 2014.
- Balasa Dinverno & Foltz's portfolio value rose 6.5% quarter-over-quarter to $872M.
Based on Balasa Dinverno & Foltz's 13F filing for Q2 2014, filed 29 Jul 2014.